BioSpace News Archive

Drug Development

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Zenas BioPharma announces The Lancet Rheumatology has published findings from a Phase 2 study evaluating obexelimab for the treatment of patients with IgG4-Related Disease (IgG4-RD).

August 1, 2023
·
4 min read
Business

Bausch + Lomb Solidifies Leadership Team

Bausch + Lomb Corporation today announced changes to its executive leadership team including the creation of two new roles.

August 1, 2023
·
3 min read
Drug Development

Qualigen Therapeutics Announces US FDA IND Clearance to Initiate Phase 1 Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Qualigen Therapeutics, Inc. announces today that the U.S. Food and Drug Administration (FDA) has cleared the Company’s IND application for QN-302, a potential best-in-class small molecule G-Quadruplex (G4)-selective transcription inhibitor.

August 1, 2023
·
5 min read
FDA

FDA Approves Harm Reduction Therapeutics’ Over-the-Counter Opioid Overdose Reversal Medication

FDA has approved Harm Reduction Therapeutics’ (HRT) new drug application for RiVive™ (Naloxone HCl Nasal Spray 3 mg) to be available over the counter (OTC) for the emergency treatment of opioid overdose.

August 1, 2023
·
3 min read
BioMidwest

Enspire DBS Therapy Announces $17.6 Million Series B Financing to Advance the Development of Deep Brain Stimulation (DBS) plus Rehabilitation for Stroke Patients

Enspire DBS Therapy, Inc. announced today that it raised $17.6 million of committed capital in a Series B financing led by existing investor, Cleveland Clinic.

August 1, 2023
·
3 min read
Genetown

Fractyl Health Announces Clinical Update on Revita® Real World Registry in Germany and Launch of Revita+™ Telehealth Program Combining Behavioral Recommendations with Revita Treatment for Type 2 Diabetes

Fractyl Health Announces Clinical Update on Revita ® Real World Registry in Germany and Launch of Revita+ ™ Telehealth Program Combining Behavioral Recommendations with Revita Treatment for Type 2 Diabetes.

August 1, 2023
·
4 min read
Business

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Champions Oncology, Inc. today announced an agreement to adopt BioVolume’s leading 3D imaging and thermal technology as their primary means of capturing efficacy results.

August 1, 2023
·
3 min read
Biotech Beach

STARmed Co., Ltd Expands Its Reach with the Launch of STARmed America in the USA

STARmed Co., Ltd, a leading medical device manufacturer specializing in thermal ablation technology, is thrilled to announce the launch of its subsidiary, STARmed America, in the USA.

August 1, 2023
·
2 min read
Biotech Bay

Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)

Jaguar Health today announced the activation by the U.S. Food and Drug Administration (FDA) of a physician-requested Investigational New Drug (IND) application to evaluate crofelemer for treatment of uncontrolled diarrhea in a patient with short bowel syndrome (SBS).

August 1, 2023
·
5 min read
Medis, the leading commercialization company for the CEE region, has appointed a new CEO

Medis, the leading commercialization company focused on improving access to innovative therapies in the countries of Central and Eastern Europe

August 1, 2023
·
2 min read